Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 17 | Ugwumba Chidozie10% Owner | Open-market sale | SELL | $64K 12.6K sh | Jan 16, 2026 traded Jan 15, 2026 | |
Flower JohannaDirector |
Open-market sale · 10b5-1 plan |
| SELL |
| $280K 600 sh |
| Jan 16, 2026 traded Jan 15, 2026 |
| 16 | Yeh Kuanling AmyChief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $34K 3,000 sh | Jan 16, 2026 traded Jan 16, 2026 |
| 15 | Hsieh Anthony LiDirector, Executive Chair, CEO & Pres., 10% Owner | Open-market sale · 10b5-1 plan | SELL | $1.10M 415.5K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 14 | Nithrakashyap ArvindDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $73K 1,045 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 14 | Wren ChrisVP of Operations | Open-market sale | SELL | $5,529 30.0K sh | Jan 16, 2026 traded Jan 16, 2026 |
| 14 | Choudary Kiran KumarChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $372K 5,427 sh | Jan 16, 2026 traded Jan 16, 2026 |
| 14 | Choudary Kiran KumarChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $968K 14.4K sh | Jan 16, 2026 traded Jan 16, 2026 |
| 13 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $145K 320 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $110K 240 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $56K 120 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $186K 400 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $108K 240 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $168K 360 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $73K 160 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | D'Amico AndrewDirector | Open-market sale · 10b5-1 plan | SELL | $30K 200 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $73K 160 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 12 | Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm | Open-market sale · 10b5-1 plan | SELL | $209K 1,010 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 11 | Burroughs Amy L.Director, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $282K 7,521 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 10 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $37K 80 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 10 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $37K 80 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 10 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $38K 80 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 10 | Cummings MarthaDirector | Open-market sale · 10b5-1 plan | SELL | $13K 2,853 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 10 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $38K 80 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 10 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $37K 80 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 9 | Hettrich KevinCHIEF FINANCIAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $104K 9,800 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 8 | Ruttenberg David W.Director | Open-market sale · 10b5-1 plan | SELL | $145K 12.5K sh | Jan 16, 2026 traded Jan 15, 2026 |
| 8 | Jarboe Scott T.CAO and Corporate Secretary | Open-market sale · 10b5-1 plan | SELL | $74K 2,151 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 8 | Scott JacobGENERAL COUNSEL AND CORP. SEC. | Open-market sale · 10b5-1 plan | SELL | $154K 21.7K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 8 | Choudary Kiran KumarChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $14K 200 sh | Jan 16, 2026 traded Jan 16, 2026 |
| 8 | Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm | Open-market sale · 10b5-1 plan | SELL | $125K 600 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 6 | Sumner CrystalSee Remarks | Open-market sale · 10b5-1 plan | SELL | $22K 5,055 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $479K 11.5K sh | Jan 16, 2026 traded Jan 16, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $383K 9,258 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 4 | Ruttenberg David W.Director | Open-market sale · 10b5-1 plan | SELL | $145K 12.5K sh | Jan 16, 2026 traded Jan 15, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $448K 10.7K sh | Jan 16, 2026 traded Jan 15, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $348K 8,467 sh | Jan 16, 2026 traded Jan 16, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $286K 7,046 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $533K 13.0K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 1 | Peer AndrewVP, Corporate Controller & CAO | Open-market sale · 10b5-1 plan | SELL | $15K 1,750 sh | Jan 16, 2026 traded Jan 15, 2026 |